QIETIFY Trademark

Trademark Overview


On Wednesday, July 17, 2019, a trademark application was filed for QIETIFY with the United States Patent and Trademark Office. The USPTO has given the QIETIFY trademark a serial number of 88519283. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 13, 2023. This trademark is owned by Zynerba Pharmaceuticals, Inc.. The QIETIFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, autism, auditory diseases and disorders, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, central nervous system diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, fragile x syndrome, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurologic...
qietify

General Information


Serial Number88519283
Word MarkQIETIFY
Filing DateWednesday, July 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, autism, auditory diseases and disorders, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, central nervous system diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, fragile x syndrome, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech diseases and disorders, and viral diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZynerba Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDevon, PA 19333

Party NameZynerba Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDevon, PA 19333

Trademark Events


Event DateEvent Description
Monday, February 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2022SOU EXTENSION 5 GRANTED
Friday, June 24, 2022SOU EXTENSION 5 FILED
Friday, July 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 24, 2022TEAS EXTENSION RECEIVED
Saturday, January 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 6, 2022SOU EXTENSION 4 GRANTED
Thursday, January 6, 2022SOU EXTENSION 4 FILED
Thursday, January 6, 2022TEAS EXTENSION RECEIVED
Friday, July 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 30, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 30, 2021SOU EXTENSION 3 FILED
Wednesday, June 30, 2021TEAS EXTENSION RECEIVED
Wednesday, January 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021SOU EXTENSION 2 GRANTED
Monday, January 4, 2021SOU EXTENSION 2 FILED
Monday, January 4, 2021TEAS EXTENSION RECEIVED
Wednesday, June 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 8, 2020SOU EXTENSION 1 GRANTED
Monday, June 8, 2020SOU EXTENSION 1 FILED
Monday, June 8, 2020TEAS EXTENSION RECEIVED
Tuesday, January 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 3, 2019ASSIGNED TO EXAMINER
Wednesday, July 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 20, 2019NEW APPLICATION ENTERED